Cargando…
Recipient Tregs: Can They Be Exploited for Successful Hematopoietic Stem Cell Transplant Outcomes?
Human and mouse CD4(+)FoxP3(+) T cells (Tregs) comprise non-redundant regulatory compartments which maintain self-tolerance and have been found to be of potential therapeutic usefulness in autoimmune disorders and transplants including allogeneic hematopoietic stem cell transplantation (allo-HSCT)....
Autores principales: | Copsel, Sabrina N., Wolf, Dietlinde, Pfeiffer, Brent, Barreras, Henry, Perez, Victor L., Levy, Robert B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253768/ https://www.ncbi.nlm.nih.gov/pubmed/35799783 http://dx.doi.org/10.3389/fimmu.2022.932527 |
Ejemplares similares
-
Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection
por: Lightbourn, Casey O., et al.
Publicado: (2021) -
BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT
por: Copsel, Sabrina N., et al.
Publicado: (2019) -
The promise of CD4(+)FoxP3(+) regulatory T-cell manipulation in vivo: applications for allogeneic hematopoietic stem cell transplantation
por: Copsel, Sabrina, et al.
Publicado: (2019) -
Utilization of Treg Cells in Solid Organ Transplantation
por: Juneja, Tanya, et al.
Publicado: (2022) -
Costimulation blockade and Tregs in solid organ transplantation
por: Muckenhuber, Moritz, et al.
Publicado: (2022)